News from Anuncia Medical

Anuncia Medical Inc. Announces Published Data with Promising Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts
SCOTTSDALE, Ariz., May 23, 2023 /PRNewswire/ -- Anuncia Medical…

Anuncia Medical, Inc., receives FDA clearance for the ReFlow® System Mini for the treatment of patients with hydrocephalus
Anuncia Medical, Inc., receives FDA clearance for the ReFlow®…

Anuncia Medical honored as participant in the 2022 Flinn Foundation Bioscience Entrepreneurship Program
Anuncia Medical, Inc. recognized as an Arizona bioscience startup…

Anuncia Medical, Inc. Selects Scottsdale, Ariz. for New HQ to Further Develop Lifesaving Medtech
Move provides emerging leader in innovation with opportunity…

The Ultimate List of Attractive MedTech M&A Targets
These are the companies in the private sector that medtech analysts…

Anuncia ReFlow™ Tech Honored With Fast Company 2021 World Changing Ideas Awards
Anuncia's breakthrough technology has received an honorable mention…

Anuncia Inc. Receives FDA “Breakthrough Device Designation” for ReFlow™ System Mini
LOWELL, Mass., March 2, 2021 /PRNewswire/ -- Anuncia Inc.,…

Looking to the Future of Neuro Devices: Exclusive Interview with Alcyone Lifesciences CEO PJ Anand
Alcyone Lifesciences is a medical technology company based out…

First-in-Human Use of ReFlow™ for Treatment of Hydrocephalus
LOWELL, Mass., May 22, 2018 /PRNewswire/ -- Anuncia, Inc.,…

Brain emergency averted at the push of a button
A Boston neurosurgeon recently avoided doing emergency brain…